KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Change in Accured Expenses (2016 - 2025)

Evolent Health (EVH) has 11 years of Change in Accured Expenses data on record, last reported at $7.4 million in Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 249.45% year-over-year to $7.4 million; the TTM value through Dec 2025 reached $3.0 million, up 113.04%, while the annual FY2025 figure was $3.0 million, 113.04% up from the prior year.
  • Change in Accured Expenses reached $7.4 million in Q4 2025 per EVH's latest filing, up from $1.5 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $43.3 million in Q2 2023 and bottomed at -$32.4 million in Q1 2022.
  • Average Change in Accured Expenses over 5 years is -$2.5 million, with a median of $1.8 million recorded in 2024.
  • Peak YoY movement for Change in Accured Expenses: soared 331.04% in 2023, then crashed 255.78% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $13.6 million in 2021, then plummeted by 205.68% to -$14.3 million in 2022, then plummeted by 106.34% to -$29.6 million in 2023, then skyrocketed by 107.11% to $2.1 million in 2024, then skyrocketed by 249.45% to $7.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were $7.4 million in Q4 2025, $1.5 million in Q3 2025, and -$8.1 million in Q2 2025.